Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 1, 2017BMJ OpenOpen Access

What drives the prescribing of growth hormone preparations in England? Prices versus patient preferences

View Full Paper
Ask AI
Bookmark
Share

Authors

SCStephen ChapmanUniversity of LeedsRFR FitzpatrickKeele UniversityMAMohammed AladulUniversity of Mosul

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Chapman et al. (2017) studied this question.

synapsesocial.com/papers/6a6f7661e71d69abee08084ehttps://doi.org/10.1136/bmjopen-2016-013730
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Surviving Sepsis Campaign: raising awareness to reduce mortality.2003 · 197 citations
  2. 2Mass transfer, clearance and plasma concentration of procalcitonin during continuous venovenous hemofiltration in patients with septic shock and acute oliguric renal failure2003 · 48 citations